Active Ingredient(s): Olopatadine Hydrochloride
FDA Approved: * April 15, 2008
Pharm Company: * ALCON RES
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Patanase Overview

Olopatadine, sold under the brand name Opatanol among others, is a medication used to decrease the symptoms of allergic conjunctivitis and allergic rhinitis (hay fever).[2] It is used as eye drops or as a nasal spray.[2] The eye drops generally result in an improvement within half an hour.[2] Common side effects include headache, sore throat, eye discomfort, change in taste.[3][2] More significant side effects may...

Read more Patanase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Patanase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Olopatadine Hydrochloride
  • Solution: 0.1%, 0.2%
  • Solution/drops: 0.1%
  • Spray: 0.6%
  • Spray, Metered: 0.665mg/spray
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Patanase: (3 results)

Sorted by National Drug Code
  • 0065-0332 Patanase 665 ug/1 Nasal Spray, Metered by Alcon Laboratories, Inc.
  • 54868-6049 Patanase 665 ug/1 Nasal Spray, Metered by Physicians Total Care, Inc.
  • 58118-9924 Patanase 665 ug/1 Nasal Spray, Metered by Clinical Solutions Wholesale

Other drugs which contain Olopatadine Hydrochloride or a similar ingredient: (2 results)